Status:
COMPLETED
Capacity Assessment in Persons With Alzheimer's Disease
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Alzheimer's Disease
Capacity to Consent to Treatment
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to assess decision-making capacity in persons with Alzheimer's disease. First, our goal is to validate four French capacity assessment tools for persons with Alzheimer's D...
Detailed Description
Study of Alzheimer's disease patients show a wide variability in decision-making abilities, especially for the consent to treatment and the ability to vote. No tools are available to assess the capaci...
Eligibility Criteria
Inclusion
- for patients with Alzheimer's disease: age \>=18 years, to be native speakers of French and French nationality, Diagnosed with a Alzheimer's disease and followed in a French "Centre Memory of Resources and Research"(CMRR)
- for control subjects: age \>=18 years, to be native speakers of French and French nationality, have no complaints of memory problems, primary caregiver of patient with AD of the same age as the patient nearly 10 years
Exclusion
- for all participants: confusion, severe psychiatric disorders, stroke, blindness, uncorrected hearing loss, refusal to participate in the study
- for patients with Alzheimer's disease: other dementia than AD
- for control subjects: diagnosed dementia
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2014
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01190800
Start Date
June 1 2010
End Date
September 1 2014
Last Update
October 15 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Louis Mourier
Colombes, France, 92700